Jessner Formula Peel
Testo originale in francese.
Prodotto naturale per la salute autorizzato in Canada
- Altri nomi
- Alumier MD Jessner Formula Peel, Alumier MD Power Glow, Alumier MD Power Glow Peel, Power Glow, Power Glow Peel
- Titolare
- Alumier Europe Ltd.
- NPN o DIN-HM
- 80071561
- Stato
- Licenza attiva
- Data della licenza
- 2 agosto 2016
- Data di revisione
- 24 settembre 2024
- Forma
- Liquide
- Via di somministrazione
- Topique
- Tipo di domanda
- Non traditionnelle
L’analisi delle dosi orali non si applica senza una via esclusivamente orale accertata.
Composizione
| Ingrediente medicinale e fonte | Per unità posologica, secondo la fonte |
|---|---|
| Acide 2-hydroxybenzoïque Fonte : Acide salicylique | 14 % |
| Acide L-lactique Fonte : Acide L-lactique | 14 % |
| 1,3-benzènediol Fonte : Résorcinol | 14 % |
Ingredienti non medicinali
Hydroxyacétophénone, Eau, Glycyrrhétinate de stéaryle, Hydroxyde de sodium, SD alcool 40-B, Propanediol, Filtré de lysat de ferment de Saccharomyces, Phényléthyle résorcinol, 1,2-Hexanediol
Dosi raccomandate in Canada
| Popolazione | Età | Quantità per assunzione | Frequenza |
|---|---|---|---|
| Adultes | Non précisée | Non précisée | Non précisée |
Usi autorizzati in Canada
Contributes to reduce the signs of chronic photo aging, by helping skin renewal. Helps to correct skin discoloration, by renewing the surface of the skin. Helps treat acne pimples. Reduces the number and/or severity of acne pimples. Penetrates pores to help control (reduce) acne pimples. Dries and helps clear up acne pimples and allows skin to heal. Helps keep skin clear of new acne pimples. Helps prevent new acne pimples from forming.
Testo originale in inglese.
Un uso autorizzato in Canada non è un’indicazione sulla salute autorizzata nell’Unione europea. Consulti il registro delle indicazioni sulla salute.
Avvertenze in Canada
Known Adverse Reactions : Some people may experience a burning sensation, dermatitis, swelling, or blisters.
Testo originale in inglese.
Cautions and Warnings : Use only as directed. For Professional Use Only. Not for Retail Sale. For external use only. Keep out of reach of children. Patient should be explained the risks associated with this product prior to administration. Test product on a small area of the patient's skin, before applying to the whole area to be treated. If application causes severe discomfort or irritation, wash the area immediately with cold water and discontinue use. If irritation persists, consult a health care practitioner. If a severe reaction occurs (e.g. such as a chemical burn, hives/blistering, swelling of eyes/mouth, blistering or difficulty breathing), seek immediate medical attention. Avoid contact with eyes and mucous membranes; if contact and irritation occur, rinse thoroughly with water. If swallowed, get medical help or contact a poison control centre immediately. This product may increase skin's sensitivity to the sun and particularly the possibility of sunburn. Please limit exposure to the sun and artificial UV light and apply a sunburn protectant while using this product and for a week afterwards. Avoid sport, swimming or the sauna for two days post treatment. Do not participate in laser or Intense Pulsed Light (IPL) facial treatments for 14 days post treatment. Using topical acne products or other chemical peels at the same time or immediately following use of this product may increase dryness or irritation of the skin. Only one product should be used, unless directed by a health care practitioner. Use caution if the patient suffers from immunosupression, is taking oral contraceptives or tetracyclines, has a recent history of medical or cosmetic treatment/procedure (e.g. laser therapy, surgical procedures, cosmetic filler, microdermabrasion,etc.), smoking, herpes simplex, dermatitis, psoriasis, or any other inflammatory condition in the skin area to be treated (as these may have an impact on wound healing).
Testo originale in inglese.
Contra-Indications : Do not use on inflamed, irritated, reddened or broken skin. For use only on Fitzpatrick skin types I-III. Not for use on individuals who are pregnant or breastfeeding, have diabetes, vitiligo, poor blood circulation, a herpetic breakout, open wounds, suspicious lesions, severely dry skin, currently suffer from any type of infection, are sensitive to aspirin/salicylic acid, have received recent chemotherapy or radiation therapy, used isotretinoin in the past 12 months or are taking photosensitizing medication.
Testo originale in inglese.
Fonte
Scheda ufficiale Health Canada, licenza 80071561
Banca dati dei prodotti naturali per la salute autorizzati (BDPSNH), Health Canada: prodotti autorizzati, ingredienti, dosi, usi e avvertenze, consultato il 27 ottobre 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Testo originale in inglese.
Testo originale in francese.
La formula venduta in Europa con lo stesso nome può essere diversa. Queste informazioni non sostituiscono il parere di un medico o farmacista.
Elenco nella revisione ufficiale del (registro: Banca dati dei prodotti naturali per la salute autorizzati (BDPSNH), Health Canada: prodotti autorizzati, ingredienti, dosi, usi e avvertenze).
Un'informazione inesatta o più recente su questo prodotto, che lei sia lettore o marca? Scriva a contact@compoatlas.com: ogni correzione è pubblicata nel registro delle correzioni.